Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Stannard

Sports Medicine Columbia, MO Medical Doctor

NPI 1720030190 CMS profile 78180

1100 Virginia Ave, Columbia, MO 65212

Open in the dashboard

General payments

$67,511

108 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$25,673 paid to institutions, not to them · program year 2019

Through program year 2025, James Stannard of Columbia, MO is reported in the CMS Open Payments database as having received $67,511 across 108 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $25,673 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 89th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $18,250 24
2024 General $6,129 17
2023 General $10,385 16
2022 General $5,030 10
2021 General $2,699 7
2020 General $19,637 19
2019 General $5,380 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Stannard
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to James Stannard were reported at $18,250. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year James Stannard Sports Medicine median Middle half National median
2019 $5,380 $1,176 $199–$4,249 $163
2020 $19,637 $708 $96–$2,890 $114
2021 $2,699 $1,213 $152–$3,994 $132
2022 $5,030 $1,230 $159–$3,998 $149
2023 $10,385 $584 $146–$2,836 $160
2024 $6,129 $628 $163–$3,168 $164
2025 $18,250 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Synthes GmbH $35,089 44 payments
  2. Medical Device Business Services, Inc. $28,041 19 payments
  3. Elite Orthopedics, LLC $2,402 4 payments
  4. DePuy Synthes Sales Inc. $1,147 25 payments
  5. Arthrex, Inc. $268 3 payments
  6. Organogenesis Inc. $227 4 payments
  7. Kerecis Limited $94 5 payments
  8. Endeavor Orthopaedics LLC $81 1 payment
  9. DePuy Synthes Products, Inc. $71 1 payment
  10. Medtronic USA, Inc. $69 1 payment
  11. Other $22 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $20,911 3 payments
  2. Travel and Lodging $17,073 27 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $15,945 11 payments
  4. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $7,688 9 payments
  5. Food and Beverage $3,261 52 payments
  6. Education $2,633 6 payments
Products named General payments · program years 2019–2025
  1. INSTRUMENTS $12,344 6 payments
  2. VA-LCP PLATES & SCREWS $11,560 6 payments
  3. LOW PROFILE PELVIC $11,346 3 payments
  4. LCP PLATES & SCREWS $497 1 payment
  5. TFN-Advance $345 6 payments
  6. NA $334 4 payments
  7. ACTIS $298 2 payments
  8. Puraply $227 4 payments
  9. TFN ADVANCED $157 5 payments
  10. Hammerlock $148 2 payments
  11. Other $1,277 39 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

24

Median for Sports Medicine: 144

Drug cost

$499

Median for Sports Medicine: $1,027

Branded share of claims

0%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 24 $499

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$28,575

Medicare's payments for the services billed

Medicare patients

51

Average age 70

Services billed

78

35 women, 16 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Arthritis 63%
Depression 45%
Heart failure 33%
COPD 33%
Osteoporosis 33%
Diabetes 29%
Chronic kidney disease 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

108 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record